Clinical Trial Update: First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 study to evaluate REGN20423 in healthy adult participants and adults with atopic dermatitis; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• REGN20423

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Healthy Volunteer, Atopic Dermatitis | Phase 1 | Status: NOT_YET_RECRUITING